Natalia Stepanova

562 total citations
91 papers, 293 citations indexed

About

Natalia Stepanova is a scholar working on Nephrology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Natalia Stepanova has authored 91 papers receiving a total of 293 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Nephrology, 24 papers in Pulmonary and Respiratory Medicine and 19 papers in Surgery. Recurrent topics in Natalia Stepanova's work include Kidney Stones and Urolithiasis Treatments (22 papers), Dialysis and Renal Disease Management (18 papers) and Therapeutic Uses of Natural Elements (11 papers). Natalia Stepanova is often cited by papers focused on Kidney Stones and Urolithiasis Treatments (22 papers), Dialysis and Renal Disease Management (18 papers) and Therapeutic Uses of Natural Elements (11 papers). Natalia Stepanova collaborates with scholars based in Ukraine, United States and Germany. Natalia Stepanova's co-authors include М. Kolesnyk, Ganna Tolstanova, І. Dudar, Michael Coppedge, Jan Teorell, Josefine Pernes, Анна Петрова, James M. Shultz, Szymon Brzόsko and Carl Henrik Knutsen and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and Atherosclerosis.

In The Last Decade

Natalia Stepanova

55 papers receiving 195 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Natalia Stepanova Ukraine 11 112 81 56 52 51 91 293
Hark Rım South Korea 11 126 1.1× 61 0.8× 50 0.9× 55 1.1× 42 0.8× 52 315
Nicholas Cole United Kingdom 11 64 0.6× 38 0.5× 21 0.4× 51 1.0× 27 0.5× 19 276
Domenico Giannese Italy 12 135 1.2× 69 0.9× 31 0.6× 75 1.4× 28 0.5× 37 334
Mohammad A. Shafiee Canada 11 76 0.7× 102 1.3× 33 0.6× 72 1.4× 54 1.1× 28 287
Niels Erik Frandsen Denmark 10 186 1.7× 48 0.6× 21 0.4× 98 1.9× 27 0.5× 16 381
José Abrão Cardeal da Costa Brazil 12 132 1.2× 46 0.6× 34 0.6× 58 1.1× 19 0.4× 31 304
Fabiola Martín-del-Campo Mexico 11 217 1.9× 32 0.4× 26 0.5× 46 0.9× 123 2.4× 31 418
Phyllis Mei‐Shan Cheng Hong Kong 14 336 3.0× 36 0.4× 37 0.7× 66 1.3× 103 2.0× 34 500
Renaat Schoonjans Belgium 11 92 0.8× 59 0.7× 74 1.3× 133 2.6× 10 0.2× 17 368

Countries citing papers authored by Natalia Stepanova

Since Specialization
Citations

This map shows the geographic impact of Natalia Stepanova's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Natalia Stepanova with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Natalia Stepanova more than expected).

Fields of papers citing papers by Natalia Stepanova

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Natalia Stepanova. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Natalia Stepanova. The network helps show where Natalia Stepanova may publish in the future.

Co-authorship network of co-authors of Natalia Stepanova

This figure shows the co-authorship network connecting the top 25 collaborators of Natalia Stepanova. A scholar is included among the top collaborators of Natalia Stepanova based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Natalia Stepanova. Natalia Stepanova is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Stepanova, Natalia, et al.. (2024). Hemodialysis dose and long-term COVID-19 outcomes – a retrospective cohort study. European Journal of Clinical and Experimental Medicine. 22(1). 107–116.
3.
Stepanova, Natalia, et al.. (2024). LOW HIGH-DENSITY LIPOPROTEIN LEVEL ASSOCIATED WITH ENHANCED INFLAMMATORY RESPONSE AND ONE-YEAR PERSISTENCE OF LONG COVID IN PATIENTS UNDERGOING HEMODIALYSIS: A CROSS-SECTIONAL COHORT STUDY. Electronic Sumy State University Institutional Repository (Sumy State University). 12(1). 128–136. 2 indexed citations
4.
Stepanova, Natalia. (2024). Type 2 Diabetes Mellitus and the Gut Microbiota: Charting New Territory for Sodium-Glucose Co-Transporter 2 Inhibitors. Eurasian Journal of Medicine and Oncology. 1–8.
6.
Stepanova, Natalia. (2024). Dyslipidemia in Peritoneal Dialysis: Implications for Peritoneal Membrane Function and Patient Outcomes. Biomedicines. 12(10). 2377–2377. 6 indexed citations
7.
Stepanova, Natalia. (2024). SGLT2 inhibitors in peritoneal dialysis: a promising frontier toward improved patient outcomes. Renal Replacement Therapy. 10(1). 8 indexed citations
8.
Stepanova, Natalia. (2023). The Gut-Peritoneum Axis in Peritoneal Dialysis and Peritoneal Fibrosis. Kidney Medicine. 5(6). 100645–100645. 14 indexed citations
9.
Stepanova, Natalia, et al.. (2023). OXALATE-DEGRADING ACTIVITY IN FECAL MICROBIOTA IS ASSOCIATED WITH OBESITY AND CARDIOVASCULAR EVENTS IN END-STAGE KIDNEY DISEASE PATIENTS. Journal of Hypertension. 41(Suppl 3). e140–e140. 1 indexed citations
10.
Stepanova, Natalia, et al.. (2023). Oxidative stress as the bridge between dyslipidemia and peritoneal ultrafiltration failure: A bi-center cross-sectional cohort study. SHILAP Revista de lepidopterología. 34–45. 1 indexed citations
11.
Stepanova, Natalia, et al.. (2023). INDICATORS OF ENERGY EFFICIENCY OF PUBLIC BUILDING. 34(1). 134–139. 1 indexed citations
12.
Stepanova, Natalia, et al.. (2023). Low high-density lipoprotein level is a risk factor for postvaccination COVID-19 in hemodialysis patients. Atherosclerosis. 379. S134–S134.
13.
Stepanova, Natalia, et al.. (2022). Pilot testing for long-term impact of glycerol-induced acute kidney injury on oxalate homeostasis in rats. SHILAP Revista de lepidopterología. 15–24. 1 indexed citations
14.
Stepanova, Natalia. (2022). How Advanced Is Our Understanding of the Role of Intestinal Barrier Dysfunction in the Pathogenesis of Recurrent Urinary Tract Infections. Frontiers in Pharmacology. 13. 780122–780122. 8 indexed citations
15.
Stepanova, Natalia, et al.. (2021). Plasma oxalic acid and cardiovascular risk in end-stage renal disease patients: a prospective, observational cohort pilot study. The Korean Journal of Internal Medicine. 37(1). 167–178. 14 indexed citations
17.
Stepanova, Natalia, et al.. (2020). The oxidative status in patients with chronic kidney disease. SHILAP Revista de lepidopterología. 92(5). 70–77. 7 indexed citations
18.
Stepanova, Natalia, et al.. (2019). Activity 0f Lipoprotein-Associated Paraoxonase-1 Enzymes and Myeloperoxidase in Patients with Chronic Kidney Disease. Ukraïnsʹkij žurnal medicini bìologìï ta sportu. 4(6). 321–328.
19.
Stepanova, Natalia, et al.. (2014). POSITIVE EFFECTS OF MODERN IMMUNOCORRECTION ACCORDING TO THE ANALYSIS OF CYTOKINES AND SLPI IN PATIENTS WITH PYELONEPHRITIS. Likarska sprava. 45–56. 4 indexed citations
20.
Stepanova, Natalia. (2010). The state family policy in West European Countries (the 1990s – the 2000s). 5(5). 88–95. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026